Captopril (Compound)

Synonyms:captopril, 62571-86-2, Capoten, L-Captopril, Lopirin, Captopryl, Garranil, Cesplon, Captolane, Tensoprel, Acepress, Captoril, Dilabar, Hypertil, Tenosbon, Alopresin, Captoprilum, Acepril, Apopril, Lopril, Acediur, Aceplus, (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid, SQ-14225, Farcopril, Hypopress, Tensiomin, Tensobon, Zapto, Captoprilum [INN-Latin], SQ 14225, D-2-Methyl-3-mercaptopropanoyl-L-proline, D-3-Mercapto-2-methylpropanoyl-L-proline, SQ 14,225, C9H15NO3S, 1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline, SA 333, D-3-Mercapto-2-methylpropionylproline, Captomax, Mepha, L-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-, (2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline, Hipertil, CHEBI:3380, L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-, NSC-757419, 1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline, (S)-1-((S)-3-mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylic acid, 9G64RSX1XD, CHEMBL1560, 1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline, MLS000069484, Asisten, DTXSID1037197, Isopresol, C09AA01, (-)-Captopril, 1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline, SA-333, (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline, L-Proline, 1-((2S)-3-mercapto-2-methyl-1-oxopropyl)-, NCGC00023654-04, SMR000059061, SQ -14225, Lopirin [Switzerland], 1-Pyrrolidinecarboxylic acid, 1-(D-3-mercapto-2-methyl-1-propionyl)-, L-(S,S)-, DTXCID9017197, Novocaptopril, Captril, Captopril (Capoten), Capozide (Salt/Mix), 3-Mercapto-2-methylpropionyl-proline, X8Z, Apopril (TN), Capoten (TN), HSDB 6527, 1-[(2s)-3-mercapto-2-methylpropionyl]-l-proline, SR-01000075603, EINECS 263-607-1, UNII-9G64RSX1XD, component of Captea (Salt/Mix), component of Acezide (Salt/Mix), component of Ecazide (Salt/Mix), 1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S), Captopril,(S), Prestwick_103, Capoten;L-Captopril, MFCD00168073, Captopril [USAN:USP:INN:BAN:JAN], SQ14534, SCHEMBL4, Spectrum_000688, CAPTOPRIL [INN], CAPTOPRIL [JAN], CAPTOPRIL [MI], CAPTOPRIL [HSDB], CAPTOPRIL [USAN], Opera_ID_1041, Prestwick3_000019, Spectrum2_001211, Spectrum3_001388, Spectrum4_000811, Spectrum5_001587, CAPTOPRIL [VANDF], Lopac-C-4042, 1-((2S)-2-Methyl-3-sulfanylpropanoyl)-L-proline #, CAPTOPRIL [MART.], Epitope ID:114065, UPCMLD-DP003, C 4042, CAPTOPRIL [USP-RS], CAPTOPRIL [WHO-DD], CAPTOPRIL [WHO-IP], Lopac0_000302, BSPBio_000057, BSPBio_002976, KBioGR_001321, KBioSS_001168, MLS001076488, DivK1c_000208, SPECTRUM1500682, SPBio_001022, Captopril (JP17/USP/INN), (S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline, BPBio1_000063, GTPL5158, CAPTOPRIL [ORANGE BOOK], Captopril for system suitability, CAPTOPRIL [EP MONOGRAPH], CAPTOPRIL [USP IMPURITY], UPCMLD-DP003:001, BDBM21642, HMS500K10, KBio1_000208, KBio2_001168, KBio2_003736, KBio2_006304, KBio3_002196, CAPTOPRIL [USP MONOGRAPH], 1j37, NINDS_000208, HMS1921C12, HMS2089P19, HMS2092I12, HMS2095C19, HMS2233I04, HMS3259G10, HMS3260N06, HMS3712C19, Pharmakon1600-01500682, SA333, CAPTOPRILUM [WHO-IP LATIN], HY-B0368, Tox21_110890, Tox21_500302, BBL033600, CCG-39104, EI-213, HB3636, NSC757419, s2051, STK802012, AKOS005622581, Captopril, >=98% (HPLC), powder, Tox21_110890_1, BCP9000485, CS-2425, DB01197, KS-5025, LP00302, NC00554, NSC 757419, SDCCGSBI-0050290.P006, IDI1_000208, SMP1_000056, NCGC00015235-01, NCGC00015235-02, NCGC00023654-03, NCGC00023654-05, NCGC00023654-06, NCGC00023654-07, NCGC00023654-08, NCGC00023654-09, NCGC00023654-10, NCGC00023654-11, NCGC00023654-13, NCGC00023654-25, NCGC00023654-26, NCGC00260987-01, AC-12047, AC-32120, SBI-0050290.P004, Captopril, meets USP testing specifications, EU-0100302, ((S)-3-mercapto-2-methylpropanoyl)-L-proline, BIM-0050290.0001, C06867, D00251, EN300-118718, AB00052156-16, AB00052156_17, AB00052156_18, Q421119, SR-01000000039, 1-[(2S)-3-Mercapto-2-methylpropionyl]- L-proline, SR-01000000039-2, SR-01000075603-1, SR-01000075603-3, 1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline, BRD-K54529596-001-04-0, BRD-K54529596-001-15-6, Captopril, British Pharmacopoeia (BP) Reference Standard, Z1269124804, Captopril, European Pharmacopoeia (EP) Reference Standard, Captopril, United States Pharmacopeia (USP) Reference Standard, (S)-1-((S)-3-mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylicacid, Captopril, Pharmaceutical Secondary Standard; Certified Reference Material, L-?Proline, 1-?[(2S)?-?3-?mercapto-?2-?methyl-?1-?oxopropyl]?-, 1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-<span class="DL">L</span>-proline, Captopril for system suitability, European Pharmacopoeia (EP) Reference Standard
Id:44093
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Captopril's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Captopril.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Captopril.

Results found

Linked to

 

Label

Description

 

Substance

A Substance

Collection

DrugPage Collection: (DrugCentralID:00484; PubChem_CID:44093, FILE=drugcentral_drug_00484.json)

Collection

Metadatata for captopril


  • Collection

    DrugPage Collection: (DrugCentralID:00484; PubChem_CID:44093, FILE=drugcentral_drug_00484.json)


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.